| Wed 5 October |
| Auditorium 1 | Auditorium 2 | Auditorium 3 | Auditorium 4 | DAY 2 | ||
8:00 | Registration | Early Career Professional (ECP) Meet & Greet |
8:00: | ||||
8:05: | 8:05: | ||||||
8:10: | 8:10: | ||||||
8:15: | 8:15: | ||||||
8:20: | 8:20: | ||||||
8:25: | 8:25: | ||||||
8:30: | 8:30: | ||||||
8:35: | 8:35: | ||||||
8:40: | 8:40: | ||||||
8:45: | 8:45: | ||||||
8:50: | 8:50: | ||||||
8:55: | 8:55: | ||||||
9:00 | Conference Welcome and Keynote Introduction |
9:00: | |||||
9:05: | Keynote Presentation ![]() 09:05 (45 mins) Rabinder Prinjha, GlaxoSmithKline |
9:05: | |||||
9:10: | 9:10: | ||||||
9:15: | 9:15: | ||||||
9:20: | 9:20: | ||||||
9:25: | 9:25: | ||||||
9:30: | 9:30: | ||||||
9:35: | 9:35: | ||||||
9:40: | 9:40: | ||||||
9:45: | 9:45: | ||||||
9:50: | ELRIG - Early Career Professional Impact Award - Supported by Elemental Machines Early Career Professional Introduction 09:50 (5 mins) Mark Soave, OMass Therapeutics ![]() 09:55 (20 mins) Shaun Pennington, LSTM |
9:50: | |||||
9:55: | 9:55: | ||||||
10:00 | 10:00 | ||||||
10:05 | 10:05 | ||||||
10:10 | 10:10 | ||||||
10:15 | Poster Prize Awards |
10:15 | |||||
10:20 | Refreshment Break | DDW - The lab of the future is now: Using AI or automation for the discovery process - Sponsored by Elemental Machines Chairs: Nicola Richmond, BenevolentAI |
Science Solutions Recruitment - Futureproof your career in Drug Discovery - Panel Discussion Chairs: Paul Mears, Science Solutions Recruitment Andrew Ratcliffe, Domainex Ltd |
10:20 | |||
10:25 | 10:25 | ||||||
10:30 | 10:30 | ||||||
10:35 | 10:35 | ||||||
10:40 | 10:40 | ||||||
10:45 | 10:45 | ||||||
10:50 | 10:50 | ||||||
10:55 | 10:55 | ||||||
11:00 | Developments in Preclinical Models Chairs: Lisa Mohamet, GlaxoSmtihKline Samantha Barichievy, AstraZeneca AB Session Introduction 11:00 (5 mins) Lisa Mohamet, GlaxoSmtihKline Samantha Barichievy, AstraZeneca AB ![]() 11:05 (30 mins) Benjamin Haibe-Kains, Princess Margaret Cancer Centre ![]() 11:35 (30 mins) Richard Cuthbert — Bio-Rad ![]() 12:05 (30 mins) Nathaniel Lam, GSK ![]() 12:35 (15 mins) Laura Calo — Ncardia |
Innovation through partnership - Sponsored by AstraZeneca Open Innovation Chairs: Kathryn Chapman, Milner Therapeutics Institute, University of Cambridge David Powell, LifeArc Session Introduction 11:00 (5 mins) Kathryn Chapman, Milner Therapeutics Institute, University of Cambridge David Powell, LifeArc KQ Labs accelerator for data driven health start-ups: why does it exist, what does it do and what difference does it make? 11:05 (30 mins) Barbara Domayne-Hayman, Francis Crick Institute Jelena Aleksic, PharmEnable Developing strategic partnerships to accelerate worldwide access to human cells 11:35 (30 mins) Kam Dhaliwal — bit.bio David Fischer — bit.bio The Joint AstraZeneca-Cancer Research Horizon Functional Genomics Centre (FGC): A partnership demonstrating how together we innovate faster and impact more 12:05 (30 mins) Douglas Ross-Thriepland, AstraZeneca Beyond Small Molecules… 12:35 (15 mins) David Madge — WuXi AppTec |
Advancements in Screening and Automation Sponsored by IDBS Chairs: Mario Richter, AbbVie Deutschland GmbH & Co. KG Kirsten Tschapalda, Roche Session Introduction 11:00 (5 mins) Mario Richter, AbbVie Deutschland GmbH & Co. KG Kirsten Tschapalda, Roche Efficient low-priced custom automation at Abbvie 11:05 (30 mins) Mario Richter, AbbVie Deutschland GmbH & Co. KG Automated analysis workflow to identify metal contamination in HTS outputs 11:35 (30 mins) Rachel Moore — Genedata AG iPSC automation platform 12:05 (30 mins) Martine Geraerts, UCB Biopharma Multiparametric drug discovery facilitated by automated liquid handling 12:35 (15 mins) Mark Graham — Beckman Coulter UK Ltd. |
Frontiers of chemistry applied to drug discovery Chairs: A Ganesan, University Of East Anglia Mary Wheldon, Drug Discovery Unit, University of Dundee Martin Swarbrick, Ryvu Therapeutics Becky Garton, Royal Society of Chemistry Session Introduction 11:00 (5 mins) A Ganesan, University Of East Anglia Martin Swarbrick, Ryvu Therapeutics Mary Wheldon, Drug Discovery Unit, University of Dundee Becky Garton, Royal Society of Chemistry Platforms for the generation and high-throughput screening of cyclic peptide libraries. 11:05 (30 mins) Ali Tavassoli, Curve Therapeutics & University of Southampton Green Chemistry at GSK - How and when to use guides, and using Green Chemistry to design a scalable route to a first-in-class BET BD2 inhibitor 11:35 (30 mins) Catherine Alder, GSK Ligand discovery in dark chemical space leading to biological insights 12:05 (30 mins) John Irwin, University of California San Francisco Oxford Nanopore Technologies - a look into the complete genome 12:35 (15 mins) Daniel Fordham — Oxford Nanopore Technologies |
11:00 | ||
11:05 | 11:05 | ||||||
11:10 | 11:10 | ||||||
11:15 | 11:15 | ||||||
11:20 | 11:20 | ||||||
11:25 | 11:25 | ||||||
11:30 | 11:30 | ||||||
11:35 | 11:35 | ||||||
11:40 | 11:40 | ||||||
11:45 | 11:45 | ||||||
11:50 | 11:50 | ||||||
11:55 | 11:55 | ||||||
12:00 | 12:00 | ||||||
12:05 | 12:05 | ||||||
12:10 | 12:10 | ||||||
12:15 | 12:15 | ||||||
12:20 | 12:20 | ||||||
12:25 | 12:25 | ||||||
12:30 | 12:30 | ||||||
12:35 | 12:35 | ||||||
12:40 | 12:40 | ||||||
12:45 | 12:45 | ||||||
12:50 | Refreshment Break - Poster Session 13.15 - 13.45 | DDW - The sustainable lab. Building a global culture of sustainability in science |
Panel discussion - Entrepreneurial Start Ups 101: Catalysing Innovation in Biomedical Science - chaired by Del Trezise Chairs: Tom Fleming, Arctoris Michael Salako, Start Codon Hanadi Jabado, Sana Capital Margaret Anne Craig, Axol Bioscience |
12:50 | |||
12:55 | 12:55 | ||||||
1:00 | 1:00: | ||||||
1:05: | 1:05: | ||||||
1:10: | 1:10: | ||||||
1:15: | 1:15: | ||||||
1:20: | 1:20: | ||||||
1:25: | 1:25: | ||||||
1:30: | DDW - The automated lab and the human Chairs: Adam Prosho, CBRE-GWS |
1:30: | |||||
1:35: | 1:35: | ||||||
1:40: | 1:40: | ||||||
1:45: | 1:45: | ||||||
1:50: | 1:50: | ||||||
1:55: | 1:55: | ||||||
2:00 | Developments in Preclinical Models ![]() 14:00 (30 mins) Mathew Garnett, Wellcome Sanger Institute ![]() 14:30 (5 mins) Karthi Rajamani — Takara Bio ![]() 14:35 (5 mins) Celine Legros — Eurofins Discovery ![]() 14:40 (30 mins) Janine Scholefield, CSIR, South Africa |
Innovation through partnership - Sponsored by AstraZeneca Open Innovation The Drug Discovery Unit: Leading the development of new anti-infective treatments with a collaborative approach 14:00 (30 mins) Beatriz Baragana, Drug Discovery Unit, University of Dundee Pressure over liquid – Established technology but with new value 14:30 (5 mins) Paul Kendall — FESTO Building a Strong Digital Foundation to Accelerate Innovation and Drug Discovery 14:35 (5 mins) Oliver Pentinmaki — Benchling Dementia Drugs through Partnership at the ALBORADA Drug Discovery Institute 14:40 (30 mins) John Skidmore, University of Cambridge |
Advancements in Screening and Automation Sponsored by IDBS Collaborative AMR Implementation in Biopharmaceutical Labs 14:00 (30 mins) Thomas Albanetti, AstraZeneca HTS Assay detection at its best! - New PHERAstar FSX features improve data quality and sample processing 14:30 (5 mins) Catherine Wark — BMG LABTECH Ltd Cost Effective Decapping 14:35 (5 mins) Adam McGinnis — Azenta Life Sciences An Educational Approach for Drug Discover Using AI Driven Closed Loop Experimentation 14:40 (30 mins) Joshua Kangas, Carnegie Mellon University |
Frontiers of chemistry applied to drug discovery Discovery of the clinical candidate, ASTX029, a dual mechanism ERK inhibitor 14:00 (30 mins) Nicola Wallis, Astex Flow Induced Dispersion Analysis (FIDA) Protein QC: Linking absolute hydrodynamic radius determination to structural insight. 14:30 (5 mins) Joanne Walter — Fida Biosystems ApS TargetMol:Targets small molecules in drug discovery 14:35 (5 mins) Phoebe Feng — Targetmol Chemicals Inc. The Discovery and Clinical Efficacy of Sisunatovir 14:40 (30 mins) Stuart Cockerill, Reviral/Pfizer |
2:00: | ||
2:05: | 2:05: | ||||||
2:10: | 2:10: | ||||||
2:15: | 2:15: | ||||||
2:20: | 2:20: | ||||||
2:25: | 2:25: | ||||||
2:30: | 2:30: | ||||||
2:35: | 2:35: | ||||||
2:40: | 2:40: | ||||||
2:45: | 2:45: | ||||||
2:50: | 2:50: | ||||||
2:55: | 2:55: | ||||||
3:00 | 3:00: | ||||||
3:05: | 3:05: | ||||||
3:10: | Refreshment Break | 3:10: | |||||
3:15: | DDW - The remote lab: Is this the future? Chairs: Martin-Immanuel Bittner, Arctoris |
3:15: | |||||
3:20: | 3:20: | ||||||
3:25: | 3:25: | ||||||
3:30: | 3:30: | ||||||
3:35: | 3:35: | ||||||
3:40: | 3:40: | ||||||
3:45: | Developments in Preclinical Models ![]() 15:45 (30 mins) Elizabeth Hardaker, Astrazeneca ![]() 16:15 (30 mins) Berend Snijder , ETH Zurich |
Innovation through partnership - Sponsored by AstraZeneca Open Innovation The benefits of working side-by-side: The Crick-GSK Biomedical LinkLabs collaboration. 15:45 (30 mins) Katrin Rittinger, Francis Crick Institute Andrew Powell, GlaxoSmithKline Advancing UK Medicines Discovery through Innovative Partnerships 16:15 (30 mins) Martin Main, Medicines Discovery Catapult |
Advancements in Screening and Automation Sponsored by IDBS Enhancing the lead discovery assay value chain by an orchestrated lab automation ecosystem 15:45 (30 mins) Federica Morandi, F Hoffmann-La Roche Kirsten Tschapalda, Roche High Throughput Affinity Screening for Rapid Hit Discovery and Prosecuting Challenging Targets 16:15 (30 mins) Poppy Llowarch, AstraZeneca |
Frontiers of chemistry applied to drug discovery Discovery and Development of Pyrukynd®: The First-in-Class Pyruvate Kinase Activator For The Treatment of Hemolytic Anemia 15:45 (30 mins) Lenny Dang, Agios Pharmaceuticals Inc Simplifying Synthesis with Electricity 16:15 (45 mins) Phil Baran, Scripps Research Institute |
3:45: | ||
3:50: | 3:50: | ||||||
3:55: | 3:55: | ||||||
4:00 | 4:00: | ||||||
4:05: | 4:05: | ||||||
4:10: | 4:10: | ||||||
4:15: | 4:15: | ||||||
4:20: | 4:20: | ||||||
4:25: | 4:25: | ||||||
4:30: | 4:30: | ||||||
4:35: | 4:35: | ||||||
4:40: | 4:40: | ||||||
4:45: | 4:45: | ||||||
4:50: | 4:50: | ||||||
4:55: | 4:55: | ||||||
5:00 | 5:00: | ||||||
5:05: | 5:05: | ||||||
5:10: | 5:10: | ||||||
5:15: | 5:15: | ||||||
5:20: | 5:20: | ||||||
5:25: | 5:25: | ||||||
5:30: | 5:30: | ||||||
5:35: | 5:35: | ||||||
5:40: | 5:40: | ||||||
5:45: | 5:45: | ||||||
5:50: | 5:50: | ||||||
5:55: | 5:55: | ||||||
6:00 | 6:00: | ||||||
6:05: | 6:05: | ||||||
6:10: | 6:10: | ||||||
6:15: | 6:15: | ||||||
6:20: | 6:20: | ||||||
6:25: | 6:25: | ||||||
6:30: | 6:30: | ||||||
6:35: | 6:35: | ||||||
6:40: | 6:40: | ||||||
6:45: | 6:45: | ||||||
6:50: | 6:50: | ||||||
6:55: | 6:55: | ||||||
7:00 | 7:00: |